These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30556497)

  • 1. Selective MMP-13 Inhibitors: Promising Agents for the Therapy of Osteoarthritis.
    Wan Y; Li W; Liao Z; Yan M; Chen X; Tang Z
    Curr Med Chem; 2020; 27(22):3753-3769. PubMed ID: 30556497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
    Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
    Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents.
    Xie XW; Wan RZ; Liu ZP
    ChemMedChem; 2017 Aug; 12(15):1157-1168. PubMed ID: 28722301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New hope for the treatment of osteoarthritis through selective inhibition of MMP-13.
    Li NG; Shi ZH; Tang YP; Wang ZJ; Song SL; Qian LH; Qian DW; Duan JA
    Curr Med Chem; 2011; 18(7):977-1001. PubMed ID: 21254976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants.
    Piecha D; Weik J; Kheil H; Becher G; Timmermann A; Jaworski A; Burger M; Hofmann MW
    Inflamm Res; 2010 May; 59(5):379-89. PubMed ID: 19902332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review.
    Mehana EE; Khafaga AF; El-Blehi SS
    Life Sci; 2019 Oct; 234():116786. PubMed ID: 31445934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis.
    Hu Q; Ecker M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.
    Nuti E; Casalini F; Avramova SI; Santamaria S; Cercignani G; Marinelli L; La Pietra V; Novellino E; Orlandini E; Nencetti S; Tuccinardi T; Martinelli A; Lim NH; Visse R; Nagase H; Rossello A
    J Med Chem; 2009 Aug; 52(15):4757-73. PubMed ID: 19606871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of
    Cuffaro D; Gimeno A; Bernardoni BL; Di Leo R; Pujadas G; Garcia-Vallvé S; Nencetti S; Rossello A; Nuti E
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of collagenolytic matrix metalloproteinases in the loss of articular cartilage in osteoarthritis.
    Smith GN
    Front Biosci; 2006 Sep; 11():3081-95. PubMed ID: 16720377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emodin ameliorates cartilage degradation in osteoarthritis by inhibiting NF-κB and Wnt/β-catenin signaling in-vitro and in-vivo.
    Ding QH; Ye CY; Chen EM; Zhang W; Wang XH
    Int Immunopharmacol; 2018 Aug; 61():222-230. PubMed ID: 29890416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ zymographic localisation of type II collagen degrading activity in osteoarthritic human articular cartilage.
    Freemont AJ; Byers RJ; Taiwo YO; Hoyland JA
    Ann Rheum Dis; 1999 Jun; 58(6):357-65. PubMed ID: 10340960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis.
    Mukherjee A; Das B
    Biomater Biosyst; 2024 Mar; 13():100090. PubMed ID: 38440290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of osteoarthritis treatment with anti-inflammatory drugs: cyclooxygenase-2 inhibitor and steroids.
    Cho H; Walker A; Williams J; Hasty KA
    Biomed Res Int; 2015; 2015():595273. PubMed ID: 26000299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of matrix metalloproteinases 2, 9, and 13 by activated protein C in human osteoarthritic cartilage chondrocytes.
    Jackson MT; Moradi B; Smith MM; Jackson CJ; Little CB
    Arthritis Rheumatol; 2014 Jun; 66(6):1525-36. PubMed ID: 24574263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis.
    Manicourt DH; Bevilacqua M; Righini V; Famaey JP; Devogelaer JP
    Drugs R D; 2005; 6(5):261-71. PubMed ID: 16128596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
    Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
    J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On-demand release of a selective MMP-13 blocker from an enzyme-responsive injectable hydrogel protects cartilage from degenerative progression in osteoarthritis.
    Roy HS; Murugesan P; Kulkarni C; Arora M; Nagar GK; Guha R; Chattopadhyay N; Ghosh D
    J Mater Chem B; 2024 Jun; 12(22):5325-5338. PubMed ID: 38669084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor.
    Attur M; Al-Mussawir HE; Patel J; Kitay A; Dave M; Palmer G; Pillinger MH; Abramson SB
    J Immunol; 2008 Oct; 181(7):5082-8. PubMed ID: 18802112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.